A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Clinical trial NCT03475953 · UNKNOWN

Trial details

NCT number: NCT03475953
Sponsor: Institut Bergonié
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Not MSI-H or MMR-deficient GIST Oesophageal or Gastric Carcinoma Biliary Tract Cancer Hepatocellular Carcinoma Soft-tissue Sarcoma Thyroid Cancer Gastro-enteropancreatic Neuroendocrine Tumor Non-small Cell Lung Cancer Solid Tumor, Adult Urothelial Carcinoma HPV-Related Carcinoma

Start date: 2018-05-04
Primary completion: 2024-12-31
Enrollment: 747

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.